Patents by Inventor Yinglin Gao

Yinglin Gao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PDGF-B antibodies and pharmaceutical composition thereof
    Patent number: 12030935
    Abstract: The present disclosure provides anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (PAH).
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: July 9, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Yinglin Gao, Scott Macdonnell, Bharathi Sundaram, Jee Kim, Isabella Del Priore, Jake Megna, Qin Ruan, Lori C. Morton
  • ANTI- PDGF-B ANTIBODIES AND METHODS OF USE FOR TREATING PULMONARY ARTERIAL HYPERTENSION (PAH)
    Publication number: 20220242943
    Abstract: The present disclosure provides anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (PAH).
    Type: Application
    Filed: January 25, 2022
    Publication date: August 4, 2022
    Inventors: Yinglin Gao, Scott Macdonnell, Bharathi Sundaram, Jee Kim, Isabella Del Priore, Jake Megna, Qin Ruan